The following fields were updated due to corrected information: d3: manufacturing location: bd caribe ltd.G2: manufacturing location: bd caribe ltd.H6: investigation summary: bd was unable to reproduce customer¿s experience with bactec product.Satisfactory results were obtained from retention samples when tested for microbial instrument detection as per quality procedures.Even though cryptococcus neoformans is not listed as a limitation in the product insert nor tested as part of the released criteria, bactec plus aerobic media can grow and recover the aforementioned organism.Therefore, this organism was test with positive results.Also, viable contamination, blood background, stainable and voltage output testing were performed, as per quality control procedures, with satisfactory results.Batch history record review did not identify any evidence for which the customer submitted the complaint.Complaint is unconfirmed based on retention samples and batch record review results.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.The specimen must be collected using sterile techniques to reduce the chance of contamination.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.
|